三阴性乳腺癌的临床试验
总计11665个结果
-
Providence Health & ServicesMerck Sharp & Dohme LLC; Brooklyn ImmunoTherapeutics, LLC主动,不招人
-
Jiangsu HengRui Medicine Co., Ltd.终止
-
Queen Mary University of LondonHoffmann-La Roche; MedSIR; Westdeutsche Studiengruppe GmbH (WSG)主动,不招人
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University暂停
-
German Breast GroupAstraZeneca; Celgene完全的
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
Mario Negri Institute for Pharmacological ResearchAssociazione Italiana per la Ricerca sul Cancro终止
-
University of VirginiaCelldex Therapeutics撤销
-
Hoffmann-La Roche完全的
-
Genentech, Inc.Hoffmann-La Roche完全的
-
Istituti Ospitalieri di Cremona未知
-
Cancer Institute and Hospital, Chinese Academy...Beijing Municipal Science & Technology Commission主动,不招人三阴性乳腺癌
-
Fudan UniversityZhejiang Cancer Hospital; Changhai Hospital; 307 Hospital of PLA; Sun Yat-sen University; The Affiliated... 和其他合作者完全的
-
Piramal Enterprises Limited终止
-
City of Hope Medical CenterNational Cancer Institute (NCI)完全的雌激素受体阴性 | HER2/Neu 阴性 | 孕激素受体阴性 | 转移性三阴性乳腺癌 | IV 期乳腺癌 AJCC v6 和 v7 | 雄激素受体阳性美国
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Stephen ShiaoMerck Sharp & Dohme LLC; Incyte Corporation招聘中
-
Antonio Giordano, MDCardiff Oncology招聘中乳腺癌 | 转移性乳腺癌 | 炎性乳腺癌 | 浸润性乳腺癌 | 局部晚期乳腺癌 | 不可切除的乳腺癌 | HER2 阴性乳腺癌 | 三阴性乳腺癌 (TNBC) | 激素受体阴性乳腺癌 | 激素受体/生长因子受体阴性乳腺癌美国
-
PIQUR Therapeutics AGHospital Universitari Vall d'Hebron Research Institute; Institut Català d'Oncologia; Hospital... 和其他合作者完全的
-
Fudan University未知
-
Memorial Sloan Kettering Cancer CenterCedars-Sinai Medical Center完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...招聘中
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘乳腺癌 | 三阴性乳腺癌
-
Hoffmann-La Roche招聘中乳腺癌大韩民国, 美国, 以色列, 丹麦, 阿根廷, 墨西哥, 巴西, 德国, 秘鲁, 波兰, 西班牙, 台湾, 南非, 捷克语, 澳大利亚